Home/Filings/4/0001787306-25-000116
4//SEC Filing

Matsuda Masaru 4

Accession 0001787306-25-000116

CIK 0001787306other

Filed

Aug 4, 8:00 PM ET

Accepted

Aug 5, 6:28 PM ET

Size

5.8 KB

Accession

0001787306-25-000116

Insider Transaction Report

Form 4
Period: 2025-08-04
Matsuda Masaru
See Remarks
Transactions
  • Sale

    Common Stock

    2025-08-04$14.33/sh6,330$90,687197,364 total
Footnotes (3)
  • [F1]The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units.
  • [F2]The price reported in Column 4 is a weighted average sale price. The shares were sold in multiple transactions at prices ranging from $13.965 to $14.675, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
  • [F3]Includes 1,095 shares purchased under the Issuer's Employee Stock Purchase Plan on May 31, 2025.

Issuer

Arcutis Biotherapeutics, Inc.

CIK 0001787306

Entity typeother

Related Parties

1
  • filerCIK 0001798679

Filing Metadata

Form type
4
Filed
Aug 4, 8:00 PM ET
Accepted
Aug 5, 6:28 PM ET
Size
5.8 KB